Income Statement Insecticides (India) Limited

Stocks

INSECTICID

INE070I01018

Agricultural Chemicals

Market Closed - Bombay S.E. 06:02:22 2026-08-18 EDT			5-day change	1st Jan Change
621.85 ^INR	+0.49%		-3.78%	-12.94%

08-12	Insecticides Limited, Q1 2027 Earnings Call, Aug 11, 2026
08-11	Insecticides Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

e3d65.hPF2NotO1HaN3Mn_3Uiaq10loGQ8xp70wRY01Uigasg.0YgyZeE7sTH3ibu4tRLP8TASySgLsc6st3JasTLrPaHIvTFGu3-APOS1qg

Published financial data: INSECTICIDES (INDIA) LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	15.04B	18.01B	19.66B	20B	21.4B
Other Revenues, Total	-	-	-	3.45M	86.72M
Total Revenues	15.04B	18.01B	19.66B	20B	21.49B
Cost of Goods Sold, Total	11.13B	13.93B	14.76B	13.78B	14.79B
Gross Profit	3.91B	4.08B	4.9B	6.23B	6.7B
Selling General & Admin Expenses, Total	916M	1.08B	1.27B	1.92B	2.19B
Provision for Bad Debts	14.04M	2.67M	2.28M	2.93M	285K
Depreciation & Amortization - (IS)	263M	261M	293M	292M	355M
Other Operating Expenses	1.27B	1.67B	2B	2.09B	2.04B
Other Operating Expenses, Total	2.46B	3.02B	3.57B	4.3B	4.58B
Operating Income	1.45B	1.06B	1.33B	1.92B	2.12B
Interest Expense, Total	-49.76M	-113M	-91.98M	-48.73M	-155M
Interest And Investment Income	5.88M	1.18M	25.69M	25.83M	5.21M
Net Interest Expenses	-43.88M	-112M	-66.3M	-22.9M	-150M
Income (Loss) On Equity Invest.	4.07M	2.32M	3.1M	5.74M	2.97M
Currency Exchange Gains (Loss)	17.04M	-106M	39.75M	27.69M	-116M
Other Non Operating Income (Expenses)	3.22M	-11.56M	-8.36M	-9.54M	4.02M
EBT, Excl. Unusual Items	1.43B	838M	1.3B	1.93B	1.86B
Gain (Loss) On Sale Of Investments	-	-	-	516K	2.48M
Gain (Loss) On Sale Of Assets	-12.92M	-665K	17.32M	1.91M	4.41M
Other Unusual Items	-	1.33M	3.38M	177K	736K
EBT, Incl. Unusual Items	1.41B	838M	1.32B	1.93B	1.87B
Income Tax Expense	339M	206M	298M	508M	473M
Earnings From Continuing Operations	1.07B	632M	1.02B	1.42B	1.39B
Net Income to Company	1.07B	632M	1.02B	1.42B	1.39B
Net Income - (IS)	1.07B	632M	1.02B	1.42B	1.39B
Net Income to Common Incl Extra Items	1.07B	632M	1.02B	1.42B	1.39B
Net Income to Common Excl. Extra Items	1.07B	632M	1.02B	1.42B	1.39B
Per Share Items
Net EPS - Basic	36.11	21.36	34.59	48.38	47.91
Basic EPS - Continuing Operations	36.11	21.36	34.59	48.38	47.91
Basic Weighted Average Shares Outstanding	29.75M	29.6M	29.6M	29.35M	29.1M
Net EPS - Diluted	36.11	21.36	34.59	48.38	47.91
Diluted EPS - Continuing Operations	36.11	21.36	34.59	48.38	47.91
Diluted Weighted Average Shares Outstanding	29.75M	29.6M	29.6M	29.35M	29.1M
Normalized Basic EPS	29.97	17.69	27.48	40.99	39.93
Normalized Diluted EPS	29.97	17.69	27.48	40.99	39.93
Dividend Per Share	2	3	3	2	2
Payout Ratio	-	23.41	8.67	4.17	4.17
Supplemental Items
EBITDA	1.69B	1.3B	1.6B	2.19B	2.44B
EBITA	1.45B	1.07B	1.34B	1.93B	2.13B
EBIT	1.45B	1.06B	1.33B	1.92B	2.12B
EBITDAR	1.69B	1.31B	1.61B	2.19B	2.47B
Total Revenues (As Reported)	15.08B	18.03B	19.76B	20.07B	21.52B
Effective Tax Rate - (Ratio)	24.01	24.6	22.56	26.33	25.32
Total Current Taxes	348M	208M	330M	559M	438M
Total Deferred Taxes	-8.57M	-2.11M	-31.25M	-51.64M	34.56M
Normalized Net Income	892M	524M	813M	1.2B	1.16B
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	4.99M	4.5M	4.23M	4.05M	5.81M
Non-Cash Pension Expense	2.56M	1.06M	1.65M	2.76M	4.83M
Supplemental Operating Expense Items
Advertising Expense	46.74M	94.23M	90.13M	525M	521M
Selling and Marketing Expenses	46.74M	94.23M	90.13M	525M	521M
Research And Development Expense From Footnotes	76.54M	89.26M	93.45M	99.9M	105M
Net Rental Expense, Total	3.1M	3.55M	5.5M	6.61M	27.89M
Imputed Operating Lease Interest Expense	1.6M	2.96M	3.24M	2.69M	26.48M
Imputed Operating Lease Depreciation	1.5M	592K	2.26M	3.93M	1.41M
Maintenance & Repair Expenses, Total	56.89M	76.95M	114M	184M	136M

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	360M	186M	612M	559M	872M
Short Term Investments	1.13M	10.14M	1.04M	11.25M	1.18M
Trading Asset Securities, Total	-	-	-	95.74M	44.48M
Total Cash And Short Term Investments	361M	196M	614M	666M	918M
Accounts Receivable, Total	2.89B	2.96B	2.97B	3.85B	4.87B
Other Receivables	10.38M	2.65M	20.76M	70.51M	57.14M
Notes Receivable	1.29M	1.92M	1.44M	2.5M	2.69M
Total Receivables	2.9B	2.97B	2.99B	3.93B	4.93B
Inventory	6.3B	8.62B	8.07B	8.86B	7.8B
Prepaid Expenses	21.19M	36.94M	43.14M	62.35M	53.14M
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	442M	504M	767M	733M	775M
Total Current Assets	10.03B	12.32B	12.48B	14.25B	14.48B
Gross Property Plant And Equipment	4.47B	5.09B	5.71B	6.1B	6.88B
Accumulated Depreciation	-1.15B	-1.37B	-1.6B	-1.83B	-2.11B
Net Property Plant And Equipment	3.33B	3.72B	4.11B	4.26B	4.77B
Long-term Investments	169M	173M	209M	201M	256M
Other Intangibles, Total	114M	126M	135M	136M	192M
Other Long-Term Assets, Total	326M	620M	202M	131M	306M
Total Assets	13.96B	16.96B	17.13B	18.98B	20B
Liabilities
Accounts Payable, Total	3.24B	4.48B	4.19B	5.08B	4.39B
Accrued Expenses, Total	219M	234M	312M	362M	329M
Short-term Borrowings	456M	1.55B	432M	640M	1.12B
Current Portion of Long-Term Debt	19.03M	22.44M	109M	121M	133M
Current Portion of Leases	20.14M	14.59M	17.97M	23.95M	37.6M
Current Income Taxes Payable	3.79M	-	-	88.01M	-
Unearned Revenue Current, Total	970M	1.15B	1.36B	1.22B	1.12B
Other Current Liabilities	152M	146M	141M	247M	266M
Total Current Liabilities	5.08B	7.6B	6.56B	7.78B	7.4B
Long-Term Debt	18.5M	18.59M	292M	235M	188M
Long-Term Leases	25.43M	21.69M	23.14M	26.46M	90.04M
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	-	-	-	27.72M	1.01M
Deferred Tax Liability Non Current	128M	127M	100M	44.31M	85.29M
Other Non Current Liabilities	16.1M	18.32M	21.84M	27.31M	29.54M
Total Liabilities	5.27B	7.78B	7B	8.14B	7.8B
Common Stock, Total	197M	296M	296M	291M	291M
Additional Paid In Capital	458M	360M	360M	-	-
Retained Earnings	8.02B	8.49B	9.43B	10.52B	11.84B
Comprehensive Income and Other	25.22M	33.77M	50.73M	38.74M	70.04M
Total Common Equity	8.7B	9.18B	10.14B	10.85B	12.2B
Total Equity	8.7B	9.18B	10.14B	10.85B	12.2B
Total Liabilities And Equity	13.96B	16.96B	17.13B	18.98B	20B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	29.6M	29.6M	29.6M	29.1M	29.1M
ECS Total Common Shares Outstanding	29.6M	29.6M	29.6M	29.1M	29.1M
Book Value / Share	293.81	310.26	342.44	372.74	419.42
Tangible Book Value	8.58B	9.06B	10B	10.71B	12.01B
Tangible Book Value Per Share	289.97	306.01	337.88	368.06	412.82
Total Debt	539M	1.63B	873M	1.05B	1.57B
Net Debt	179M	1.43B	260M	380M	653M
Debt Equivalent of Unfunded Proj. Benefit Obligation	15.35M	22.3M	38.32M	72.65M	38.57M
Debt Equivalent Oper. Leases	24.81M	28.39M	43.97M	52.9M	223M
Equity Method Investments, Total	103M	106M	110M	115M	118M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	2.71B	3.77B	2.96B	3.1B	2.97B
Inventories - Work In Process, Total	604M	880M	964M	787M	637M
Inventories - Finished Goods, Total	2.97B	3.95B	4.13B	4.95B	4.15B
Inventories - Others	17M	12.36M	20.2M	26.15M	47.52M
Land - (BS)	8.85M	10.46M	1.62M	1.62M	1.62M
Buildings, Total	931M	1.05B	1.12B	1.14B	1.36B
Machinery, Total	2.25B	2.43B	2.67B	2.81B	3.67B
Full Time Employees	1.3K	1.47K	1.62K	1.73K	1.75K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	146M	149M	176M	231M	276M

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	1.07B	632M	1.02B	1.42B	1.39B
Depreciation & Amortization - CF	255M	251M	281M	278M	339M
Amortization of Goodwill and Intangible Assets - (CF)	6.84M	8.03M	9.38M	10.83M	12.24M
Depreciation & Amortization, Total	262M	259M	290M	288M	352M
Amortization of Deferred Charges, Total - (CF)	1.49M	2.18M	2.17M	3.06M	3.32M
(Gain) Loss From Sale Of Asset	12.92M	665K	-17.32M	-1.91M	-4.41M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-516K	-2.48M
(Income) Loss On Equity Investments - (CF)	-4.07M	-2.32M	-3.1M	-5.74M	-2.97M
Provision and Write-off of Bad Debts	50.04M	5.2M	29.5M	58.39M	44.96M
Other Operating Activities, Total	-28.09M	10.16M	252M	152M	19.72M
Change In Accounts Receivable	-386M	-73.14M	-25.37M	-940M	-1.01B
Change In Inventories	306M	-2.31B	548M	-789M	1.06B
Change In Accounts Payable	-379M	1.26B	-280M	911M	-748M
Change in Other Net Operating Assets	439M	111M	17.46M	-162M	-101M
Cash from Operations	1.35B	-106M	1.84B	935M	1B
Capital Expenditure	-673M	-875M	-490M	-373M	-946M
Sale of Property, Plant, and Equipment	3.72M	7.33M	53.6M	26.19M	20.35M
Investment in Marketable and Equity Securities, Total	756M	871K	-769K	-56.27M	54.8M
Other Investing Activities, Total	5.83M	2.36M	7.34M	25.77M	6.05M
Cash from Investing	93.09M	-864M	-430M	-377M	-865M
Short Term Debt Issued, Total	-	1.1B	-	221M	482M
Long-Term Debt Issued, Total	15.08M	28.98M	447M	70.86M	79.99M
Total Debt Issued	15.08M	1.13B	447M	292M	562M
Short Term Debt Repaid, Total	-463M	-	-1.03B	-	-
Long-Term Debt Repaid, Total	-38.94M	-48.79M	-197M	-155M	-161M
Total Debt Repaid	-502M	-48.79M	-1.23B	-155M	-161M
Repurchase of Common Stock	-592M	-	-	-619M	-
Common Dividends Paid	-	-148M	-88.79M	-59.2M	-58.2M
Common & Preferred Stock Dividends Paid	-	-148M	-88.79M	-59.2M	-58.2M
Other Financing Activities, Total	-67.24M	-132M	-110M	-69.86M	-168M
Cash from Financing	-1.15B	797M	-981M	-611M	175M
Net Change in Cash	295M	-174M	426M	-53.56M	313M
Supplemental Items
Cash Interest Paid	67.24M	132M	110M	69.86M	168M
Cash Income Tax Paid (Refund)	406M	306M	135M	418M	561M
Levered Free Cash Flow	1.27B	-1.05B	831M	291M	-218M
Unlevered Free Cash Flow	1.3B	-981M	889M	321M	-121M
Change In Net Working Capital	-804M	1.03B	-253M	800M	854M
Net Debt Issued / Repaid	-487M	1.08B	-782M	137M	402M

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	6.41	4.3	4.89	6.65	6.79
Return on Total Capital	9.8	6.64	7.64	10.51	10.32
Return On Equity %	12.71	7.07	10.6	13.55	12.1
Return on Common Equity	12.71	7.07	10.6	13.55	12.1
Margin Analysis
Gross Profit Margin %	25.98	22.65	24.92	31.13	31.19
SG&A Margin	6.09	6	6.45	9.59	10.18
EBITDA Margin %	11.21	7.23	8.14	10.93	11.35
EBITA Margin %	9.66	5.95	6.83	9.67	9.92
EBIT Margin %	9.62	5.91	6.78	9.62	9.86
Income From Continuing Operations Margin %	7.14	3.51	5.21	7.1	6.49
Net Income Margin %	7.14	3.51	5.21	7.1	6.49
Net Avail. For Common Margin %	7.14	3.51	5.21	7.1	6.49
Normalized Net Income Margin	5.93	2.91	4.14	6.02	5.41
Levered Free Cash Flow Margin	8.43	-5.84	4.23	1.45	-1.01
Unlevered Free Cash Flow Margin	8.64	-5.45	4.52	1.61	-0.56
Asset Turnover
Asset Turnover	1.07	1.16	1.15	1.11	1.1
Fixed Assets Turnover	4.86	5.11	5.02	4.78	4.76
Receivables Turnover (Average Receivables)	5.53	6.16	6.63	5.87	4.91
Inventory Turnover (Average Inventory)	1.72	1.87	1.77	1.63	1.77
Short Term Liquidity
Current Ratio	1.97	1.62	1.9	1.83	1.96
Quick Ratio	0.64	0.42	0.55	0.59	0.79
Operating Cash Flow to Current Liabilities	0.27	-0.01	0.28	0.12	0.14
Days Sales Outstanding (Average Receivables)	65.95	59.28	55.18	62.23	74.39
Days Outstanding Inventory (Average Inventory)	211.67	195.42	206.82	224.38	205.7
Average Days Payable Outstanding	115.62	86.72	111.64	116.21	125.92
Cash Conversion Cycle (Average Days)	162	167.99	150.36	170.41	154.16
Long Term Solvency
Total Debt/Equity	6.2	17.72	8.61	9.65	12.87
Total Debt / Total Capital	5.84	15.05	7.93	8.8	11.4
LT Debt/Equity	0.51	0.44	3.11	2.41	2.28
Long-Term Debt / Total Capital	0.48	0.37	2.86	2.2	2.02
Total Liabilities / Total Assets	37.72	45.87	40.85	42.86	38.98
EBIT / Interest Expense	29.06	9.43	14.49	39.48	13.64
EBITDA / Interest Expense	34.33	11.73	17.65	45.4	15.91
(EBITDA - Capex) / Interest Expense	20.81	3.98	12.32	37.75	9.81
Total Debt / EBITDA	0.32	1.23	0.54	0.47	0.64
Net Debt / EBITDA	0.1	1.08	0.16	0.17	0.26
Total Debt / (EBITDA - Capex)	0.52	3.63	0.77	0.57	1.03
Net Debt / (EBITDA - Capex)	0.17	3.19	0.23	0.21	0.43
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.9	19.77	9.16	1.72	7.42
Gross Profit, 1 Yr. Growth %	12.33	4.41	20.08	27.12	7.61
EBITDA, 1 Yr. Growth %	12.22	-22.83	22.92	36.89	11.47
EBITA, 1 Yr. Growth %	12.86	-26.19	25.16	44.36	10.11
EBIT, 1 Yr. Growth %	12.95	-26.39	25.23	44.57	10.1
Earnings From Cont. Operations, 1 Yr. Growth %	14.4	-41.16	61.94	39.13	-1.84
Net Income, 1 Yr. Growth %	14.4	-41.16	61.94	39.13	-1.84
Normalized Net Income, 1 Yr. Growth %	10.09	-41.27	55.35	48.35	-3.42
Diluted EPS Before Extra, 1 Yr. Growth %	19.24	-40.95	61.94	40.28	-0.97
Accounts Receivable, 1 Yr. Growth %	13.48	2.54	0.14	29.88	26.38
Inventory, 1 Yr. Growth %	-4.64	36.73	-6.36	9.77	-11.96
Net Property, Plant and Equip., 1 Yr. Growth %	16.19	11.92	10.35	3.7	11.89
Total Assets, 1 Yr. Growth %	-2.09	21.5	1.01	10.41	5.38
Tangible Book Value, 1 Yr. Growth %	6.06	5.53	10.41	7.29	12.16
Common Equity, 1 Yr. Growth %	6	5.6	10.37	7.2	12.52
Cash From Operations, 1 Yr. Growth %	-13.2	-107.88	-1.83K	-50.02	7.26
Capital Expenditures, 1 Yr. Growth %	39.3	29.99	-43.96	-23.96	153.67
Levered Free Cash Flow, 1 Yr. Growth %	431.57	-182.97	-179.03	-67.64	-174.85
Unlevered Free Cash Flow, 1 Yr. Growth %	393.87	-175.56	-190.56	-66.4	-137.55
Dividend Per Share, 1 Yr. Growth %	50	50	0	-33.33	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.04	12.62	14.34	5.38	4.53
Gross Profit, 2 Yr. CAGR %	5.55	8.3	11.97	23.55	16.96
EBITDA, 2 Yr. CAGR %	3.12	-6.94	-2.6	29.63	23.52
EBITA, 2 Yr. CAGR %	2.77	-8.73	-3.88	34.32	26.08
EBIT, 2 Yr. CAGR %	2.71	-8.82	-3.99	34.44	26.16
Earnings From Cont. Operations, 2 Yr. CAGR %	11.18	-17.95	-2.38	49.89	16.87
Net Income, 2 Yr. CAGR %	11.18	-17.95	-2.38	49.89	16.87
Normalized Net Income, 2 Yr. CAGR %	13.01	-19.6	-4.48	51.6	19.69
Diluted EPS Before Extra, 2 Yr. CAGR %	13.5	-16.03	-2.22	50.51	17.86
Accounts Receivable, 2 Yr. CAGR %	-4.95	7.87	1.33	14.05	28.12
Inventory, 2 Yr. CAGR %	10.17	14.19	13.15	1.41	-1.7
Net Property, Plant and Equip., 2 Yr. CAGR %	11.62	14.03	11.13	7.02	7.72
Total Assets, 2 Yr. CAGR %	3.86	9.07	10.78	5.78	7.86
Tangible Book Value, 2 Yr. CAGR %	9.13	5.8	7.95	8.74	9.7
Common Equity, 2 Yr. CAGR %	9.02	5.8	7.96	8.68	9.83
Cash From Operations, 2 Yr. CAGR %	-25.33	-73.84	16.71	196.47	-26.78
Capital Expenditures, 2 Yr. CAGR %	52.26	34.57	-14.65	-34.7	38.89
Levered Free Cash Flow, 2 Yr. CAGR %	-18.95	110.02	-19.02	-47.41	-50.78
Unlevered Free Cash Flow, 2 Yr. CAGR %	-20.56	93.17	-17.28	-42.78	-64.48
Dividend Per Share, 2 Yr. CAGR %	-13.4	50	22.47	-18.35	-18.35
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.01	9.73	11.46	9.97	6.05
Gross Profit, 3 Yr. CAGR %	2.01	5.17	12.09	16.81	17.99
EBITDA, 3 Yr. CAGR %	-4.12	-6.37	2.11	9.05	23.27
EBITA, 3 Yr. CAGR %	-5.53	-7.97	1.4	10.02	25.71
EBIT, 3 Yr. CAGR %	-5.6	-8.09	1.35	9.98	25.78
Earnings From Cont. Operations, 3 Yr. CAGR %	-4.36	-10.07	2.92	9.75	30.17
Net Income, 3 Yr. CAGR %	-4.36	-10.07	2.92	9.75	30.17
Normalized Net Income, 3 Yr. CAGR %	-2.5	-9.15	0.14	10.52	30.44
Diluted EPS Before Extra, 3 Yr. CAGR %	-3.04	-8.67	4.52	10.18	30.91
Accounts Receivable, 3 Yr. CAGR %	5.76	-2.52	5.23	10.07	18.02
Inventory, 3 Yr. CAGR %	-3.67	18.39	6.88	12.03	-3.26
Net Property, Plant and Equip., 3 Yr. CAGR %	10	11.72	12.79	8.63	8.62
Total Assets, 3 Yr. CAGR %	0.99	9.43	6.31	10.78	5.65
Tangible Book Value, 3 Yr. CAGR %	9.56	7.92	7.31	7.66	9.87
Common Equity, 3 Yr. CAGR %	9.52	7.86	7.3	7.64	9.94
Cash From Operations, 3 Yr. CAGR %	0.43	-64.71	5.74	-11.5	111.26
Capital Expenditures, 3 Yr. CAGR %	21.08	44.44	0.49	-17.86	2.65
Levered Free Cash Flow, 3 Yr. CAGR %	-16.91	-18.31	51.62	-38.78	-40.85
Unlevered Free Cash Flow, 3 Yr. CAGR %	-15.23	-21.88	50.07	-37.22	-50.27
Dividend Per Share, 3 Yr. CAGR %	14.47	4	31.04	0	-12.64
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.63	10.91	10.5	7.97	8.63
Gross Profit, 5 Yr. CAGR %	9.51	5.86	5.88	12.17	14.01
EBITDA, 5 Yr. CAGR %	8.61	-2.74	-3.52	6.64	10.16
EBITA, 5 Yr. CAGR %	8.64	-4.24	-4.87	7.06	10.6
EBIT, 5 Yr. CAGR %	8.59	-4.29	-4.96	7.01	10.59
Earnings From Cont. Operations, 5 Yr. CAGR %	12.47	-5.59	-3.58	10.32	8.22
Net Income, 5 Yr. CAGR %	12.47	-5.59	-3.58	10.32	8.22
Normalized Net Income, 5 Yr. CAGR %	11.53	-6.73	-3.3	11.5	7.49
Diluted EPS Before Extra, 5 Yr. CAGR %	13.41	-4.71	-2.68	11.53	9.61
Accounts Receivable, 5 Yr. CAGR %	6.43	4.76	3.97	3.8	13.85
Inventory, 5 Yr. CAGR %	8.16	16.17	2.73	11.28	3.38
Net Property, Plant and Equip., 5 Yr. CAGR %	6.89	9.08	10.45	9.82	10.75
Total Assets, 5 Yr. CAGR %	7.37	11.14	4.8	7.96	7
Tangible Book Value, 5 Yr. CAGR %	13.28	10.88	8.91	8.25	8.22
Common Equity, 5 Yr. CAGR %	13.36	10.88	8.89	8.19	8.27
Cash From Operations, 5 Yr. CAGR %	101.99	-43.31	6.65	-17.32	-8.39
Capital Expenditures, 5 Yr. CAGR %	36.12	25.42	5.27	5.14	14.39
Levered Free Cash Flow, 5 Yr. CAGR %	40.33	-2.94	-17.76	-31.51	-1.81
Unlevered Free Cash Flow, 5 Yr. CAGR %	57.85	-5.62	-16.06	-31.02	-14.43
Dividend Per Share, 5 Yr. CAGR %	8.45	17.61	17.61	-5.59	8.45